Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | Revisão |
| 语言: | 英语 |
| 出版: |
2020
|
| 在线阅读: | https://doi.org/10.1080/14737159.2020.1768849 |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|